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Schizophrenia is a common psychiatric diagnosis affecting approximately 0.7% of the popu-
lation worldwide (1). Cognitive symptoms in schizophrenia, such as impaired memory, poor
attention/information processing, and difficulties with executive functions, are a core feature of
schizophrenia and strongly related to quality of life and functional outcomes, yet generally respond
poorly to current treatment options (2, 3). Further research exploring the basis of cognitive
impairments in schizophrenia is essential to allow for better targeted treatment options. Improved
cognition would pave a much better path to functional recovery for people with schizophrenia, for
example, increasing the chances of someone being able to return towork or studywhen their positive
psychotic symptoms are stabilized. One avenue that has emerged as a way to study symptoms of
schizophrenia, such as cognition, is the study of schizotypy. Schizotypy refers to subclinical psychotic
experiences (which can include odd behaviors, strange speech, unusual perceptual experiences, and
social anhedonia) that are distributed along a continuum, from mental health to a diagnosable
psychiatric disorder. While the term schizotypy was coined over six decades ago (4), research
examining schizotypal traits in non-clinical populations has rapidly expanded over the last few
years (a recent PsychInfo search of the term “schizotypy” – conducted 19/05/2015 – showed
more than 5850 publications, with more than half of those publications in the last 5 years). The
exploration of schizotypymay help elucidatemany factors related to the etiology and development of
schizophrenia spectrum psychopathology, including cognition. It is timely and important to collate
current research exploring schizotypy and determine how this avenue of research can inform our
understanding of cognition across the schizophrenia spectrum.
The aim of this Research Topic is to provide updated knowledge, reviews, and opinion pieces
in relation to cognition, schizotypy, and the schizophrenia continuum. Drawing on a variety of
perspectives and collating the results of several experimental studieswill informon the current status
of schizotypy research and allow future research directions to be identified. Three key sectionswill be
explored: schizotypy as a construct, including theoretical and methodological considerations when
assessing schizotypy; a comprehensive review of dopaminergic contributions to schizotypy; and,
several empirical research studies exploring cognition and symptomatology across the schizophrenia
and schizotypy spectrum.
Schizotypy has been conceptualized as both taxonic/categorical and dimensional. The categorical
approach (5) is based on a disease model of mental illness and considers schizotypy to be a
subclinical expression of the symptoms of schizophrenia that are present in a small subgroup of
the population (approximately 10%). The fully dimensional approach (6) stems from Eysenck’s
dimensional views of personality and describes schizotypy as continuous throughout the general
population with higher levels of schizotypy, in combination with other etiological risk factors, to
indicate a greater risk for developing schizophrenia. In this Research Topic, Mason (7) provides an
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interesting opinion piece that acknowledges that while there are
theoretical differences between these models, both dimensional
and categorical approaches may have validity and research utility
in relation to schizotypy.
While the study of schizotypy is interesting in its own right (for
example, as a dimension of personality), schizotypy also offers a
number of advantages for studying schizophrenia liability. While
many of the confounding factors associated with schizophrenia,
such as hospitalization, social isolation, medication/illicit drug
use, and health complications, can be controlled when using
a non-clinical schizotypy population, there remain extraneous
factors that should be considered when schizotypy samples are
employed. Neill (8), in this Research Topic, considers some of
thesemethodological issues, such as age, education, relative status,
abuse history, and religion, when recruiting and analyzing schizo-
typy samples. As Neill concludes, schizotypy research is rapidly
expanding and it is critical that as this field moves forward, the
many potential influences on schizotypy are considered to ensure
studies are well designed and statistically valid.
There is considerable evidence indicating an overlap between
schizotypy and schizophrenia in relation to behavioral, cognitive,
brain structure, and brain function measures. At a neurochemical
level, there is a long-standing literature linking dopamine to the
pathophysiology of schizophrenia (9, 10) and an accumulating
literature indicating a role for dopamine in schizotypy. In this
Research Topic, Mohr and Ettinger (11) review the association
between dopamine, schizotypy, and cognition across a wide range
of methods, including experimental pharmacological challenge
studies, dopamine-sensitive cognitive and behavioral measures,
molecular studies of genes that involve dopamine transmission,
and molecular imaging studies of the dopamine system. The
authors conclude that there is some evidence of an association
between altered dopamine neurotransmission and schizotypy,
particularly positive schizotypy. Importantly, the authors provide
suggestions for future avenues of research that will inform neu-
robiological and cognitive models of the schizophrenia spectrum,
paving the way for potential neuropharmacological treatments.
The second key component of this Research Topic presents sev-
eral empirical studies exploring different aspects of cognition and
symptomatology across the schizophrenia/schizotypy continuum.
There is a long history of experimental paradigms that attempt
to induce psychotic-like experiences (such as perceptual distur-
bances, paranoia, and anhedonia),many of these involving various
means of sensory deprivation. The effects of brief sensory depri-
vation and the associated experience of psychotic-like experiences
are explored in this Research Topic by Daniel et al. (12) in relation
to schizotypal traits (high- vs. low-hallucination proneness). The
study findings indicate that sensory deprivation can be a useful,
non-pharmacological tool for temporarily inducing psychotic-like
states across all individuals, with schizotypal traits relating to
greater levels of perceptual distortions.
The multidimensionality of schizotypy is addressed in several
studies in this Research Topic. Ford and Crewther (13) explore
shared phenotypes across the autism and schizophrenia spectrum
disorders. They conducted a factor analysis on items from the
autism spectrum quotient (AQ) and the schizotypal personality
questionnaire (SPQ) in a non-clinical population. Results revealed
a social disorganization phenotype common to both schizotypy
and autism, as well as factors specific to both spectrums of
personality.
Two studies are presented that explore the link between
schizotypy and neurocognition. Louise et al. (14) investigate neu-
rocognition and schizotypy subtypes or factors using the Oxford-
Liverpool inventory of feelings and experiences (O-LIFE) in an
adult community sample that accounted for psychiatric illness
and family history; and hence, allowing for the exploration of
both cognitive functioning and potential compensatory mecha-
nisms in individuals who have passed the peak onset times for
developing schizophrenia. Results indicated a positive relation-
ship between poorer inhibitory control and the schizotypy fac-
tors of positive schizotypy, cognitive disorganization, and impul-
sive non-conformity, as well as a positive relationship between
negative schizotypy and poorer attention/processing speed and
reasoning and problem-solving capacity. Herzig et al. (15), in
this Research Topic, explore neurocognition and schizotypy, with
their primary focus being how substance use attenuates cog-
nition. In their university-aged sample, Herzig et al. found a
trend toward higher positive schizotypy scores in their “cannabis
users” group (as compared to the non-cannabis users). In rela-
tion to the three cognitive tasks that they assessed (verbal short-
term recall, trail-making task, and two-back working mem-
ory task), they failed to find a relationship between schizotypy
scores and cognition, but found enhanced cannabis use pre-
dicted decreased verbal short-term memory, whereas enhanced
alcohol use predicted reduced working memory performance.
These results highlight the potential importance of controlling for
substance use when exploring the links between schizotypy and
cognition.
An interesting study assessing the integrity of body represen-
tations in individuals with schizophrenia is presented by Graham
et al. (16), with their focus on passivity symptoms (i.e., the belief
that one’s thoughts or actions are controlled by an external agent).
Their results highlight self-abnormalities in schizophrenia and
provide evidence for both stable trait abnormalities and state
changes that depend on passivity symptom profiles. Batty et al.
(17) explore neurophysiological correlates of face processing in
schizotypy. Their results suggest that high schizotypes (as mea-
sured by the cognitive disorganization factor of the O-LIFE)
demonstrate neurophysiological anomalies relating to the early,
configural stages of face processing (N170 component), a finding
that has been demonstrated in schizophrenia samples. As the
authors discuss, the high schizotypal group demonstrated intact
behavioral performance indicating anomalies in neural processes
during the earlier stages of face processing are possibly corrected
during the later stages of processing.
Within the framework of the dimensional model of schizotypy,
high levels of schizotypy are not necessarily pathological but
possibly beneficial, particularly in relation to positive schizotypy
(18). For example, there is much research positing a link between
high schizotypy and the socially valued cognitive attribute of
creativity [e.g., Ref. (18, 19)]. In this Research Topic, Grant et al.
(20) explore the interactions between positive schizotypy and
verbal intelligence in relation to stimulus ambiguity and false-
positive errors. The findings from Grant et al.’s study indicate that
both state and trait positive schizotypy explain much of the vari-
ance in the production of false-positive errors/stimulus ambiguity
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(or by inference, hallucinatory experiences) and verbal intelli-
gence moderates the relationship between schizotypy and the
production of false-positive perceptions of ambiguous stimuli.
In relation to potential interventions across the psychosis spec-
trum, Lim and Gleeson (21), in this Research Topic, explore the
link between loneliness and the psychosis spectrum. The authors
highlight the growing interest in the relationship between loneli-
ness and mental health disorders; and note that the more specific,
and crucial, relationship between loneliness and psychotic disor-
ders has been overlooked. A well-designed intervention to target
loneliness for individuals with psychosis is warranted and may
even reduce the risk of developing psychosis or experiencing a
relapse of psychotic symptoms. Lim and Gleeson provide helpful
guidelines to move this area of research forward.
To conclude, the articles in this Research Topic represent an
interesting array of opinions, reviews, and empirical studies that
contribute to the study of schizotypy. Collectively, they highlight
the heuristic potential of the study of schizotypy, particularly in
relation to better understanding cognition across the schizophre-
nia spectrum.
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